Shirley Uitte De Willige

Title: The Innovative Contributions of Shirley Uitte De Willige

Introduction

Shirley Uitte De Willige is a notable inventor based in Leeds, GB. She has made significant contributions to the field of genetics, particularly in the area of deep venous thrombosis. Her work has implications for understanding genetic risks associated with this condition.

Latest Patents

Shirley holds a patent for a method of screening for the presence of a genetic defect associated with deep venous thrombosis. The patent describes a method for identifying a genetic marker in an individual's genome that indicates an increased risk of developing this condition. Specifically, the genetic marker is haplotype 2 of the fibrinogen γ gene (FGG-H2). The method involves detecting a set of mutations in the nucleic acid material encoding fibrinogen γ, which includes specific mutations such as 129A/T (rs2066854), 7874G/A (rs206681), 9615'C/T (rs2066864), and 10034C/T (rs2066865). This innovative approach has the potential to enhance screening processes and improve patient outcomes.

Career Highlights

Shirley is currently employed at bioMérieux, Inc., where she continues to advance her research in genetics and diagnostics. Her work at the company reflects her commitment to applying scientific discoveries to real-world medical challenges.

Collaborations

Shirley collaborates with esteemed colleagues, including Maria Catharina Henrica De Visser-van Soest and Hans Luuk Vos. These partnerships foster a collaborative environment that enhances the quality and impact of their research.

Conclusion

Shirley Uitte De Willige's contributions to the field of genetics, particularly through her patent on screening for genetic defects related to deep venous thrombosis, highlight her innovative spirit and dedication to improving healthcare. Her work exemplifies the importance of research in understanding genetic risks and developing effective screening methods.